Page last updated: 2024-10-20

pyridoxal phosphate and Liver Dysfunction

pyridoxal phosphate has been researched along with Liver Dysfunction in 58 studies

Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.

Research Excerpts

ExcerptRelevanceReference
"The MRI characteristics of a multifocal inflammatory pseudotumor of the liver are described."5.31Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings. ( de Hemptinne, B; Elewaut, A; Mortelé, KJ; Praet, M; Ros, PR; Wiesner, W, 2002)
" Adverse events and discomfort were recorded and graded in all patients."2.42Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis. ( de Beeck, BO; Fagertun, H; Fog, AF; Kane, P; Martí-Bonmatí, L, 2003)
"Hepatocyte-containing liver neoplasms such as hepatomas or focal nodular hyperplasia (FNH), take up MnDPDP and demonstrate varying degrees of enhancement."1.31MnDPDP enhanced magnetic resonance imaging of focal liver lesions. ( Burkill, GJ; Healy, JC; King, LJ; Murray-Lyons, I; Scurr, ED; Vlavianos, P, 2002)
"The MRI characteristics of a multifocal inflammatory pseudotumor of the liver are described."1.31Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings. ( de Hemptinne, B; Elewaut, A; Mortelé, KJ; Praet, M; Ros, PR; Wiesner, W, 2002)
" Contrast agents were injected according to the currently recommended practices; Gd-DTPA was injected as a rapid bolus injection in a dosage of 0."1.29Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. ( Brown, ED; Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Warshauer, DM, 1996)
"After carbon tetrachloride poisoning the enzyme activity in the plasma increased within 2 h but was not enhanced by pyridoxal 5'-phosphate."1.26Changes in activation of aspartate aminotransferase by pyridoxal 5'-phosphate after experimental liver damage in rabbits. ( Barnard, HC; de Waal, A; le Roux, S; Potgieter, GM; Schoombie, EM, 1982)

Research

Studies (58)

TimeframeStudies, this research(%)All Research%
pre-199023 (39.66)18.7374
1990's19 (32.76)18.2507
2000's15 (25.86)29.6817
2010's1 (1.72)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tarrant, J1
Meyer, D1
Katavolos, P1
Harr, KE1
Allison, K1
Bonde, RK1
Murphy, D1
Harvey, JW1
Seale, MK1
Catalano, OA1
Saini, S4
Hahn, PF3
Sahani, DV1
Ni, Y2
Cresens, E1
Adriaens, P1
Dymarkowski, S1
Bogaert, J1
Zhang, H1
Bosmans, H1
Verbruggen, A1
Marchal, G2
King, LJ1
Burkill, GJ1
Scurr, ED1
Vlavianos, P1
Murray-Lyons, I1
Healy, JC1
Halavaara, J1
Abo-Ramadan, U1
Markkola, A1
Aronen, H1
Häkkinen, AM1
Martí-Bonmatí, L1
Fog, AF1
de Beeck, BO1
Kane, P1
Fagertun, H1
SHEID, B1
MORRIS, HP1
ROTH, JS1
Reimer, P1
Schneider, G1
Schima, W2
Ba-Ssalamah, A1
Happel, B1
Kettenbach, J1
Dirisamer, A1
Wrba, F1
Längle, F1
Faraj, BA1
Camp, VM1
Caplan, DB1
Ahmann, PA1
Kutner, M1
Dols, JL1
van Zanten, AP1
de Waal, A1
le Roux, S1
Potgieter, GM1
Barnard, HC1
Schoombie, EM1
Majumdar, SK1
Shaw, GK1
O'Gorman, P1
Aps, EJ1
Offerman, EL1
Thomson, AD1
Al-Mudhaffar, SA1
Naash, M1
Matloff, DS1
Selinger, MJ1
Kaplan, MM1
Anderson, BB1
O'Brien, H1
Griffin, GE1
Mollin, DL1
Mitchell, DG1
Outwater, EK1
Matteucci, T1
Rubin, DL1
Chezmar, JL1
Rofsky, NM2
Earls, JP1
Slater, GJ1
Mayo-smith, WW1
Sharma, P1
Eisenberg, PJ1
Kettritz, U2
Warshauer, DM1
Brown, ED1
Schlund, JF2
Eisenberg, LB2
Semelka, RC3
Wilbur, K1
Schmid, A1
Schmid, H1
Wang, C1
Jung, G1
Heindel, W1
Krahe, T1
Kugel, H1
Walter, C1
Fischbach, R1
Klaus, H1
Lackner, K1
Coffin, CM1
Diche, T1
Mahfouz, A1
Alexandre, M1
Caseiro-Alves, F1
Rahmouni, A1
Vasile, N1
Mathieu, D1
Clément, O1
Siauve, N1
Cuénod, CA1
Vuillemin-Bodaghi, V1
Leconte, I1
Frija, G1
Martin, DR1
Chung, JJ1
Balci, NC1
Wilber, K1
Grimm, J2
Müller-Hülsbeck, S1
Blume, J1
Biederer, J1
Heller, M1
De Gaspari, A1
De Cobelli, F1
Del Maschio, A1
Yoneda, K1
Mortelé, KJ1
Wiesner, W1
de Hemptinne, B1
Elewaut, A1
Praet, M1
Ros, PR1
Oudkerk, M1
Torres, CG1
Song, B1
König, M1
Fernandez-Cuadrado, J1
Op de Beeck, B1
Marquardt, M1
van Dijk, P1
de Groot, JC1
Braga, HJ1
Choti, MA1
Lee, VS1
Paulson, EK1
Siegelman, ES1
Bluemke, DA1
Bergmeyer, HU2
Bowers, GN2
Horder, M2
Moss, DW2
Scheibe, P1
Wahlefeld, AW1
Rossouw, JE2
Labadarios, D2
Davis, M2
Williams, R3
Jung, K1
Ohlrich, B1
Mildner, D1
Zubek, A1
Schimmelpfennig, W1
Egger, E1
Ratnaike, S1
McConnell, JB1
Moore, RE1
Mitchell, D1
Wagner, C1
Stone, WJ1
Wilkinson, GR1
Schenker, S1
Rosalki, SB1
Bayoumi, RA1
Vogl, TJ2
Hammerstingl, R1
Schnell, B2
Eibl-Eibesfeldt, B1
Peqios, W1
Lissner, J2
Hamm, B1
Branding, G1
Taupitz, M1
Wolf, KJ1
Weinreb, JC2
Andersen, K1
Kaad, PH1
Bernardino, ME2
Young, SW3
Lee, JK2
Rummeny, EJ1
Peters, PE1
Weinreb, J1
Kakuma, S1
Leevy, CB1
Frank, O1
Baker, H1
Simpson, BB1
Ratner, AV1
Matkin, C1
Carter, EA1
Zaman, SN1
Tredger, JM1
Johnson, PJ1
Francesconi, G1
Mellina, S1
Massarrat, S1

Reviews

13 reviews available for pyridoxal phosphate and Liver Dysfunction

ArticleYear
Use of optimized aminotransferase methods in regulated preclinical studies.
    Veterinary clinical pathology, 2013, Volume: 42, Issue:4

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Li

2013
Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis.
    European radiology, 2003, Volume: 13, Issue:7

    Topics: Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Magne

2003
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
    European radiology, 2004, Volume: 14, Issue:4

    Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neopl

2004
[MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
    Der Radiologe, 2004, Volume: 44, Issue:12

    Topics: Chelating Agents; Contrast Media; Edetic Acid; Gadolinium; Humans; Image Enhancement; Image Interpre

2004
Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Magnetic resonance imaging clinics of North America, 1996, Volume: 4, Issue:1

    Topics: Adrenal Gland Diseases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clini

1996
[Possibilities and limitations of drugs to protect the liver].
    Tierarztliche Praxis, 1996, Volume: 24, Issue:6

    Topics: Amino Acids; Animals; Biotin; Carnitine; Fructosediphosphates; Glucose; Immunologic Factors; Ketoglu

1996
Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities.
    Acta radiologica (Stockholm, Sweden : 1987), 1997, Volume: 38, Issue:4 Pt 2

    Topics: Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Edetic Acid; Humans;

1997
Liver-specific MR imaging contrast agents.
    Radiologic clinics of North America, 1998, Volume: 36, Issue:2

    Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Liver; Liver D

1998
Mechanisms of action of liver contrast agents: impact for clinical use.
    Journal of computer assisted tomography, 1999, Volume: 23 Suppl 1

    Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Injections, Intraven

1999
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
    La Radiologia medica, 2001, Volume: 102, Issue:3

    Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DT

2001
[Aspartate aminotransferase (glutamic oxalacetic transaminase) and alanine aminotransferase (glutamic pyruvic transaminase)].
    Rinsho byori. The Japanese journal of clinical pathology, 2001, Volume: Suppl 116

    Topics: Alanine Transaminase; Apoenzymes; Aspartate Aminotransferases; Biliary Tract Diseases; Biomarkers; C

2001
Pyridoxine and its metabolism in chronic liver disease.
    Nutrition reviews, 1977, Volume: 35, Issue:6

    Topics: Alcoholism; Chemical and Drug Induced Liver Injury; Chronic Disease; Humans; Liver; Liver Diseases;

1977
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
    Der Radiologe, 1992, Volume: 32, Issue:5

    Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Mag

1992

Trials

7 trials available for pyridoxal phosphate and Liver Dysfunction

ArticleYear
Adrenal gland enhancement at MR imaging with Mn-DPDP.
    Radiology, 1995, Volume: 194, Issue:3

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Edetic Acid; Female; Humans; Liver

1995
Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
    Clinical radiology, 1996, Volume: 51, Issue:7

    Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver; Liver Diseases;

1996
Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
    European radiology, 1999, Volume: 9, Issue:3

    Topics: Adenoma, Liver Cell; Adult; Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Contrast Media; Diagnos

1999
[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2001, Volume: 173, Issue:3

    Topics: Adenoma; Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cysts; Diagnosis, Diffe

2001
Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.
    Radiology, 2002, Volume: 223, Issue:2

    Topics: Adult; Aged; Chi-Square Distribution; Contrast Media; Diagnosis, Differential; Edetic Acid; Female;

2002
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
    Bildgebung = Imaging, 1992, Volume: 59, Issue:4

    Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadol

1992
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
    Radiology, 1992, Volume: 182, Issue:1

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Fe

1992

Other Studies

38 other studies available for pyridoxal phosphate and Liver Dysfunction

ArticleYear
Comparison of blood aminotransferase methods for assessment of myopathy and hepatopathy in Florida manatees (Trichechus manatus latirostris).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2008, Volume: 39, Issue:2

    Topics: Alanine Transaminase; Animals; Animals, Wild; Aspartate Aminotransferases; Blood Specimen Collection

2008
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
    Radiographics : a review publication of the Radiological Society of North America, Inc, 2009, Volume: 29, Issue:6

    Topics: Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Di

2009
Exploring multifunctional features of necrosis avid contrast agents.
    Academic radiology, 2002, Volume: 9 Suppl 2

    Topics: Animals; Contrast Media; Edetic Acid; Gadolinium DTPA; Half-Life; Liver Diseases; Liver Neoplasms; M

2002
MnDPDP enhanced magnetic resonance imaging of focal liver lesions.
    Clinical radiology, 2002, Volume: 57, Issue:12

    Topics: Adenoma, Liver Cell; Adult; Aged; Cholangiocarcinoma; Contrast Media; Edetic Acid; Female; Focal Nod

2002
MnDPDP-enhanced magnetization transfer MR imaging: implications for effective liver imaging.
    Magnetic resonance imaging, 2003, Volume: 21, Issue:1

    Topics: Contrast Media; Edetic Acid; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Im

2003
DISTRIBUTION AND ACTIVITY OF ASPARTATE AMINOTRANSFERASE IN SOME RAPIDLY PROLIFERATING TISSUES.
    The Journal of biological chemistry, 1965, Volume: 240

    Topics: Animals; Aspartate Aminotransferases; Electrophoresis; Embryo, Mammalian; Embryo, Nonmammalian; Huma

1965
Abnormal regulation of pyridoxal 5'-phosphate in Reye's syndrome.
    Clinical chemistry, 1983, Volume: 29, Issue:10

    Topics: Adolescent; Alanine Transaminase; Child; Child, Preschool; Female; Humans; Infant; Length of Stay; L

1983
Clinical implications of differences between two recommended procedures for determination of aspartate aminotransferase.
    Clinical chemistry, 1983, Volume: 29, Issue:3

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Chemistry, Clinical; Female; Heart Diseases; Huma

1983
Changes in activation of aspartate aminotransferase by pyridoxal 5'-phosphate after experimental liver damage in rabbits.
    Clinica chimica acta; international journal of clinical chemistry, 1982, Jul-15, Volume: 122, Issue:3

    Topics: Animals; Aspartate Aminotransferases; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Live

1982
Blood vitamin status (B1, B2, B6, folic acid and B12) in patients with alcoholic liver disease.
    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 1982, Volume: 52, Issue:3

    Topics: Adult; Alcoholism; Folic Acid; Hepatitis; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Middle

1982
Kinetics of alkaline phosphatase in serum of liver diseased, anemic and normal Iraqi individuals.
    Biochemistry and experimental biology, 1980, Volume: 16, Issue:2

    Topics: Adolescent; Adult; Age Factors; Alkaline Phosphatase; Anemia; Female; Humans; Kinetics; Liver Diseas

1980
Hepatic transaminase activity in alocholic liver disease.
    Gastroenterology, 1980, Volume: 78, Issue:6

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Fatty Liver; Hepatitis; Humans; Liver; Liver Cirr

1980
Hydrolysis of pyridoxal-5'-phosphate in plasma in conditions with raised alkaline phosphate.
    Gut, 1980, Volume: 21, Issue:3

    Topics: Alkaline Phosphatase; Bone and Bones; Humans; Hydrolysis; Liver Diseases; Pyridoxal Phosphate

1980
Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
    European radiology, 1996, Volume: 6, Issue:1

    Topics: Adipose Tissue; Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Human

1996
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
    Magnetic resonance imaging, 1996, Volume: 14, Issue:10

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gado

1996
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Acta radiologica. Supplementum, 1998, Volume: 415

    Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Bar

1998
Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs.
    Magnetic resonance imaging, 1998, Volume: 16, Issue:8

    Topics: Abdomen; Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Kidney; Liver; Liver Diseases; Li

1998
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
    Magnetic resonance imaging, 2000, Volume: 18, Issue:8

    Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia

2000
Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings.
    European radiology, 2002, Volume: 12, Issue:2

    Topics: Adult; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Gadolinium; Granuloma, Pl

2002
Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis.
    Radiology, 2002, Volume: 223, Issue:2

    Topics: Adult; Aged; Chi-Square Distribution; Contrast Media; Edetic Acid; Female; Humans; Liver Diseases; M

2002
IFCC method for aspartate aminotransferase. Appendix A. Description of pertinent factors in obtaining optimal conditions for measurement.
    Clinica chimica acta; international journal of clinical chemistry, 1976, Jul-15, Volume: 70, Issue:2

    Topics: Aspartate Aminotransferases; Heart Diseases; Humans; Hydrogen-Ion Concentration; Kinetics; Liver Dis

1976
Optimization of methods for aspartate aminotransferase and alanine aminotransferase.
    Clinical chemistry, 1978, Volume: 24, Issue:1

    Topics: Alanine Transaminase; Anions; Aspartate Aminotransferases; Glutamates; Heart Diseases; Humans; Hydro

1978
Vitamin B6 and aspartate aminotransferase activity in chronic liver disease.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1978, Mar-25, Volume: 53, Issue:12

    Topics: Aspartate Aminotransferases; Chronic Disease; Humans; Liver Cirrhosis; Liver Diseases; Necrosis; Pyr

1978
The apoenzyme of aspartate aminotransferase and alanine aminotransferase in the serum of healthy persons and patients suffering from liver diseases.
    Clinica chimica acta; international journal of clinical chemistry, 1978, Dec-01, Volume: 90, Issue:2

    Topics: Alanine Transaminase; Apoenzymes; Apoproteins; Aspartate Aminotransferases; Enzyme Activation; Femal

1978
Apoenzyme of aspartate aminotransferase in serum in health and disease.
    Clinica chimica acta; international journal of clinical chemistry, 1977, Feb-01, Volume: 74, Issue:3

    Topics: Apoenzymes; Apoproteins; Aspartate Aminotransferases; Cytoplasm; Female; Humans; Liver Diseases; Mal

1977
Vitamin B6 deficiency in chronic liver disease--evidence for increased degradation of pyridoxal-5'-phosphate.
    Gut, 1977, Volume: 18, Issue:1

    Topics: Alcoholism; Chronic Disease; Humans; Liver Diseases; Pyridoxal Phosphate; Pyridoxic Acid; Pyridoxine

1977
Aspartate aminotransferase activity in human serum. Factors to be considered in supplementation with pyridoxal 5'-phosphate in vitro.
    Clinical chemistry, 1976, Volume: 22, Issue:11

    Topics: Acute Disease; Aspartate Aminotransferases; Enzyme Activation; Evaluation Studies as Topic; Glutamat

1976
Abnormal regulation of plasma pyridoxal 5'-phosphate in patients with liver disease.
    Gastroenterology, 1976, Volume: 71, Issue:6

    Topics: Acute Disease; Adult; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Diseases; Liver Functi

1976
Activation by pyridoxal 5-phosphate of aspartate transaminase in serum of patients with heart and liver disease.
    Clinica chimica acta; international journal of clinical chemistry, 1975, Mar-24, Volume: 59, Issue:3

    Topics: Aspartate Aminotransferases; Chronic Disease; Clinical Enzyme Tests; Enzyme Activation; Humans; Live

1975
Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
    Magnetic resonance quarterly, 1992, Volume: 8, Issue:3

    Topics: Adult; Contrast Media; Edetic Acid; Female; Humans; Kidney; Liver; Liver Diseases; Magnetic Resonanc

1992
Congenital sideroblastic anaemia with intrauterine symptoms and early lethal outcome.
    Acta paediatrica (Oslo, Norway : 1992), 1992, Volume: 81, Issue:8

    Topics: Anemia; Anemia, Sideroblastic; Blood Transfusion; Blood Transfusion, Intrauterine; Female; Fetal Dis

1992
Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
    Radiology, 1992, Volume: 183, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver; Live

1992
Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.
    Investigative radiology, 1991, Volume: 26 Suppl 1

    Topics: Contrast Media; Drug Evaluation; Edetic Acid; Humans; Liver; Liver Diseases; Magnetic Resonance Imag

1991
Pyridoxal phosphate annuls acetaldehyde inhibition of uridine uptake by hepatocytes.
    Alcohol and alcoholism (Oxford, Oxfordshire), 1989, Volume: 24, Issue:1

    Topics: Acetaldehyde; Benzylamines; Depression, Chemical; Drug Evaluation; Humans; In Vitro Techniques; Live

1989
MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
    Magnetic resonance in medicine, 1989, Volume: 10, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Contrast Media; Edetic Acid; Ethanol; Galactosamine

1989
Vitamin B6 concentrations in patients with chronic liver disease and hepatocellular carcinoma.
    British medical journal (Clinical research ed.), 1986, Jul-19, Volume: 293, Issue:6540

    Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Humans; Liver Diseases; Liver Neoplasms; Middle

1986
[Clinical trial of a new coenzymatic complex (Ro 8-0743-4)].
    La Clinica terapeutica, 1972, Aug-15, Volume: 62, Issue:3

    Topics: Adult; Aged; Anorexia Nervosa; Cobamides; Coenzymes; Drug Combinations; Evaluation Studies as Topic;

1972
[Studies on the in vitro aging of transaminases in serum and tissue extract].
    Enzymologia biologica et clinica, 1965, Volume: 5, Issue:4

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Cytoplasm; Enzymes; Humans; In Vitro Techniques;

1965